3fq9: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3fq9.png|left|200px]] | [[Image:3fq9.png|left|200px]] | ||
{{STRUCTURE_3fq9| PDB=3fq9 | SCENE= }} | {{STRUCTURE_3fq9| PDB=3fq9 | SCENE= }} | ||
===Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications=== | ===Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications=== | ||
{{ABSTRACT_PUBMED_19773552}} | {{ABSTRACT_PUBMED_19773552}} | ||
==About this Structure== | ==About this Structure== | ||
[[3fq9]] is a 4 chain structure of [[Molecular Playground/Insulin]]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FQ9 OCA]. | |||
==See Also== | |||
*[[Molecular Playground/Insulin|Molecular Playground/Insulin]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019773552</ref><references group="xtra"/> | ||
[[Category: Katsoyannis, P.]] | [[Category: Katsoyannis, P.]] | ||
[[Category: Phillips, N.]] | [[Category: Phillips, N.]] | ||
| Line 39: | Line 30: | ||
[[Category: Hormone]] | [[Category: Hormone]] | ||
[[Category: Insulin design]] | [[Category: Insulin design]] | ||
[[Category: Rational]] | [[Category: Rational]] | ||
[[Category: Receptor-binding]] | [[Category: Receptor-binding]] | ||
[[Category: Secreted]] | [[Category: Secreted]] | ||
[[Category: Therapeutic implication]] | [[Category: Therapeutic implication]] | ||
Revision as of 09:03, 27 July 2012
Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications
Template:ABSTRACT PUBMED 19773552
About this Structure
3fq9 is a 4 chain structure of Molecular Playground/Insulin. Full crystallographic information is available from OCA.
See Also
Reference
- Zhao M, Wan ZL, Whittaker L, Xu B, Phillips NB, Katsoyannis PG, Ismail-Beigi F, Whittaker J, Weiss MA. Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications. J Biol Chem. 2009 Nov 13;284(46):32178-87. Epub 2009 Sep 22. PMID:19773552 doi:10.1074/jbc.M109.028399